Form 4: Adicet Bio CFO Reports Routine Tax Withholding

Adicet Bio's Chief Financial Officer, Brian Nicholas Harvey, reported a disposition of 546 common shares for tax withholding purposes following restricted stock unit vesting.

Summary

• Brian Nicholas Harvey, Chief Financial Officer of Adicet Bio, Inc., reported a transaction on January 24, 2026.
• The transaction involved the disposition of 546 shares of Adicet Bio Common Stock at a price of $8.44 per share.
• This disposition was for tax withholding obligations related to the vesting of restricted stock units and does not represent a discretionary sale by Mr. Harvey.
• Following this transaction, Mr. Harvey beneficially owns 5,145 shares of Common Stock.
• The reported beneficial ownership reflects a 1-for-16 reverse stock split effected by Adicet Bio on December 30, 2025.

Sentiment

Score: 6

Explanation: The transaction is a routine tax withholding event associated with the vesting of restricted stock units, not a discretionary sale. This is a standard part of executive compensation and does not indicate a change in management's sentiment towards the company. The reverse stock split is noted but not explained in terms of its impact on sentiment.

Positives

• The transaction is a routine tax withholding event, indicating the vesting of restricted stock units, which is a positive for employee compensation and retention.
• The disposition was not a discretionary sale by the reporting person, mitigating concerns about insider selling.

Negatives

• No direct negatives are present as the transaction is administrative and not a discretionary sale.

Future Outlook

No specific forward-looking statements or guidance are provided in this filing.

Management Comments

• "Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person."
• "Reflects a 1-for-16 reverse stock split effected by the Issuer on December 30, 2025."

Industry Context

This filing reports a routine insider transaction (tax withholding) and mentions a past corporate action (reverse stock split). It does not provide direct insights into broader industry trends or competitive landscape.

Related Party Transactions

• The transaction involves the Chief Financial Officer and the company, which is a related party dealing for compensation purposes (RSU vesting and tax withholding).

Stakeholder Impact

• Shareholders: The impact is minimal as this is a routine administrative transaction and not a discretionary sale.
• Employees (specifically the CFO): The vesting of restricted stock units is a positive event for the CFO as part of their compensation package.

Key Dates

Recommendation

This Form 4 reports a routine tax withholding transaction by the CFO related to RSU vesting, which is a standard administrative event and not indicative of discretionary buying or selling. While the filing notes a recent reverse stock split, it provides no new information to alter an investment thesis. Therefore, a 'hold' recommendation is appropriate as this filing does not present new material information to warrant a change in investment strategy.

Keywords

Adicet Bio, ACET, Form 4, Insider Transaction, CFO, Brian Nicholas Harvey, Stock Vesting, Tax Withholding, Restricted Stock Units, Reverse Stock Split